Dark

LGND
Ligand Pharmaceuticals Inc.
stock NASDAQ

At Close

Jan 7, 2026 3:59:56 PM EST

199.88USD+1.969%(+3.86)181,867

198.88Bid 201.05Ask 2.17Spread

Pre-market

Jan 2, 2026 8:58:30 AM EST

190.11USD-3.015%(-5.91)0

After-hours

Jan 6, 2026 4:00:30 PM EST

196.02USD+0.018%(+0.03)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.94B

CEO

John Higgins

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Feb 26, 2026 (50d)

Last Dividend

Apr 3, 20072.500

Last Split

Nov 19, 20101for5.9999reverse

AMGN SPPI GSK BAX BMY JNJ LLY PFE MRK GTXI XLV

LGND Stats

Avg. Vol. 10 Day

132,221

Avg. Vol. 30 Day

206,240

Employees

Market Cap

3,935,556,731

Shares Out.

19,681,720

On/Off Exchange

57%/43%

6 Month Beta

0.93

1 Year Beta

0.86

2 Year Beta

0.98

3 Year Beta

0.97

52 Week Low

93.58

52 Week High

212.49

SMA50

195.48

SMA200

148.88

1 Week

+5.76%

1 Month

+8.28%

3 Month

+9.17%

6 Month

+75.77%

1 Year

+81.27%

2 Year

+168.94%

5 Year

+86.50%

Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $199.88, and today's volume is 181,867. LGND is up 1.969% today. The 30 day average volume is 206,240. LGND market cap is 3.94B with 19,681,720 shares outstanding.